92.7K
Downloads
254
Episodes
DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.
Episodes
Thursday Nov 16, 2017
Thursday Nov 16, 2017
Saudi Arabia has the largest population and economy in the Gulf region; the Saudi Food & Drug Authority (SFDA) has correspondingly grown into one of the region’s leading regulatory agencies. The SFDA is one of many regional regulatory agencies participating in DIA EMEA's Middle East Regulatory Conference 2017 in Kuwait City. “It’s very important for us as a regulatory authority,” explains Dr. Sami Al-Sager, SFDA Executive Director for Cosmetic Products Safety, and Acting Vice President for Drug Affairs, in this Global Forum podcast.
Monday Nov 13, 2017
Monday Nov 13, 2017
Information is king – but to be most useful, information must be accurately and fairly communicated, explains DIA EMEA’s 11th Annual Medical Information and Communications Conference Co-Chair Dr. Lillian Auberson (Medical Information Lead for Europe at Hoffmann-La Roche, Switzerland) in this Global Forum podcast. “It’s really about thoroughly understanding exactly why we’re being asked a question,” concurs Co-Chair Janet Davies (Director, Medical Information, EMEA, Gilead Sciences Europe, UK).
Monday Nov 06, 2017
Monday Nov 06, 2017
“We generally view the introduction of new technology solutions, particularly very expensive ones, as those that would contribute to a level of efficiency and speed,” suggests Dr. Ken Getz, Research Associate Professor at the Tufts Center for the Study of Drug Development. But, what does the Center’s recent 2017 eClinical Landscape Study reveal? Listen to find out, and learn more about technology's growing and often surprising impact at DIA’s Regulatory Submissions, Information & Document Management Forum.
Friday Nov 03, 2017
Friday Nov 03, 2017
Vicki Edwards, QPPV and Vice President, Pharmacovigilance Excellence, for AbbVie, Inc. (UK), has served on the program committee for every DIA EMEA Annual Forum for QPPVs in Europe, and in this Global Forum podcast discusses the impact of Brexit and relocation of the EMA on pharmacovigilance in the EU. To learn more, attend DIA EMEA's Brexit Summit: Ensuring Continuity for Patients and Business.